Nervenarzt. 2011 May;82(5):657-64; quiz 665-6.

[Antidepressant therapy in coronary artery disease].

[Article in German]

Source

Klinik und Poliklinik für Psychiatrie und Psychotherapie, LVR-Klinikum, Heinrich-Heine-Universität, Bergische Landstraße 2, 40629, Düsseldorf. christian.lange-asschenfeldt@lvr.de

Abstract

Depression is considered an independent risk factor for coronary artery disease (CAD) and other vascular conditions. Moreover, comorbid depressive disorder in CAD patients carries an increased risk of cardiac events and mortality. Among survivors of acute myocardial infarction, up to 20% meet diagnostic criteria for major depression, the presence of which carries a fivefold increased risk of cardiac death within 6 months. Heart patients with depressive comorbidity require particular care for both adequate treatment of their affective disorder and reduction of their cardiac risk. Antidepressant treatment must follow established guidelines; special care is needed to avoid cardiac side effects. In this review, we discuss the pathophysiological and prognostic significance of comorbid depression in CAD and weigh risks and benefits of available treatment options - particularly different drug classes and psychotherapy - in light of recent study results.

PMID:: 21109992; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

English Abstract

MeSH Terms

Substances

Antidepressive Agents

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Antidepressants - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Review Treatment-resistant depression and mortality after acute coronary syndrome. [Am J Psychiatry. 2009]
Review Treatment-resistant depression and mortality after acute coronary syndrome.
Carney RM, Freedland KE. Am J Psychiatry. 2009 Apr; 166(4):410-7. Epub 2009 Mar 16.
Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study. [J Thromb Thrombolysis. 2009]
Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study.
van Zyl LT, Lespérance F, Frasure-Smith N, Malinin AI, Atar D, Laliberté MA, Serebruany VL. J Thromb Thrombolysis. 2009 Jan; 27(1):48-56. Epub 2008 Jan 11.
[Drawing up guidelines for the attendance of physical health of patients with severe mental illness]. [Encephale. 2009]
[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM, avec le soutien institutionnel du laboratoire Lilly. Encephale. 2009 Sep; 35(4):330-9. Epub 2009 Jul 9.
Review [Comorbidity of depressive disorders and cardiovascular diseases. Implications for diagnosis, pharmaco- and psychotherapy]. [Nervenarzt. 2002]
Review [Comorbidity of depressive disorders and cardiovascular diseases. Implications for diagnosis, pharmaco- and psychotherapy].
Hesslinger B, Härter M, Barth J, Klecha D, Bode C, Walden J, Bengel J, Berger M. Nervenarzt. 2002 Mar; 73(3):205-17; quiz 218.
Major depressive disorder treatment guidelines in America and Europe. [J Clin Psychiatry. 2010]
Major depressive disorder treatment guidelines in America and Europe.
Davidson JR. J Clin Psychiatry. 2010; 71 Suppl E1:e04.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

[Antidepressant therapy in coronary artery disease].
[Antidepressant therapy in coronary artery disease].
Nervenarzt. 2011 May ;82(5):657-64; quiz 665-6.

PubMed
Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evid...
Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals.
J Pharmacol Exp Ther. 1990 May ;253(2):867-76.

PubMed
Evolutionary origins of oxygen sensing in animals.
Evolutionary origins of oxygen sensing in animals.
EMBO Rep. 2011 Jan ;12(1):3-4. Epub 2010 Nov 26 .

PubMed
Observation of de novo bladder dysfunction under treatment with Her2-neu antibod...
Observation of de novo bladder dysfunction under treatment with Her2-neu antibodies.
Urol Int. 2011 Feb ;86(1):80-4. Epub 2010 Nov 27 .

PubMed
Use of IFN-gamma in patients with AIDS.
Use of IFN-gamma in patients with AIDS.
J Acquir Immune Defic Syndr. 1990 ;3(6):584-90.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: